Johnson Kevin Bruce 4
4 · Tourmaline Bio, Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Johnson Kevin Bruce
Chief Regulatory Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-01-27+58,000→ 58,000 totalExercise: $17.00Exp: 2035-01-26→ Common Stock (58,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as to 25% of the shares on January 27, 2026, with the remainder vesting in 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.